Biochemical Markers of Coagulation Activation in Mitral Stenosis, Atrial Fibrillation, and Cardiomyopathy

Overview

Journal Clin Cardiol

Specialty Cardiology & Vascular Diseases

Date 1997 Jan 1

PMID 8994731

Citations 7

Authors

U Ikeda

K Yamamoto

K Shimada

Affiliations

Soon will be listed here.

Abstract

Advances in the understanding of the biochemistry of the mechanism of hemostasis have led to the development of sensitive methods for determining levels of markers which reflect thrombin activity (thrombin-antithrombin III complex, fibrinopeptide A, F1 + 2 fragment), active fibrinolysis (D-dimer, plasmin-alpha 2-plasmin inhibitor complex), and platelet activity (platelet factor 4, beta-thromboglobulin) in vivo. Measurement of these markers may be useful in identifying patients with various cardiovascular disorders at high risk of thromboembolism.

Citing Articles

Evolution of Coagulation and Platelet Activation Markers After Transcatheter Edge-to-Edge Mitral Valve Repair.

Hadjadj S, Beaudoin J, Beaupre F, Gravel C, Marsit O, Pouliot S J Clin Med. 2025; 14(3).

PMID: 39941501 PMC: 11818723. DOI: 10.3390/jcm14030831.

Assessment of Coagulation Factors in Patients with Severe Rheumatic Mitral Stenosis in Sinus Rhythm with Left Atrial Appendage Inactivity.

Mukhopadhyay S, Chauhan N, Muheeb G, Yusuf J, Mehta V, Mahajan B CJC Open. 2024; 6(10):1231-1239.

PMID: 39525339 PMC: 11544275. DOI: 10.1016/j.cjco.2024.07.004.

Ulinastatin reduces postoperative bleeding and red blood cell transfusion in patients undergoing cardiac surgery: A PRISMA-compliant systematic review and meta-analysis.

Yao Y, Fang N, Liu D, Li L Medicine (Baltimore). 2020; 99(7):e19184.

PMID: 32049853 PMC: 7035067. DOI: 10.1097/MD.0000000000019184.

D-Dimer assay as a non invasive test for the diagnosis of left atrial Thrombi in Indian patients with Rheumatic MS.

Rajappa M, Sunil Roy T, Raj A, Trehan V, Mallika V Afr Health Sci. 2013; 13(3):584-589.

PMID: 24250293 PMC: 3824422. DOI: 10.4314/ahs.v13i3.9.

Effects of ulinastatin on coagulation in high-risk patients undergoing off-pump coronary artery bypass graft surgery.

Kim N, Shim J, Bang S, Sim J, Song J, Kwak Y Korean J Anesthesiol. 2013; 64(2):105-11.

PMID: 23459312 PMC: 3581777. DOI: 10.4097/kjae.2013.64.2.105.

References

Ezekowitz M, Bridgers S, James K, CARLINER N, Colling C, Gornick C . Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. N Engl J Med. 1992; 327(20):1406-12. DOI: 10.1056/NEJM199211123272002. View

SZEKELY P . SYSTEMIC EMBOLISM AND ANTICOAGULANT PROPHYLAXIS IN RHEUMATIC HEART DISEASE. Br Med J. 1964; 1(5392):1209-12. PMC: 1814317. DOI: 10.1136/bmj.1.5392.1209. View

JAFRI S, Caceres L, Rosman H, Ozawa T, Mammen E, Lesch M . Activation of the coagulation system in women with mitral stenosis and sinus rhythm. Am J Cardiol. 1992; 70(13):1217-9. DOI: 10.1016/0002-9149(92)90062-4. View

COSNETT J, Pudifin D . EMBOLIC COMPLICATIONS OF CARDIOMYOPATHY. Br Heart J. 1964; 26:544-8. PMC: 1018174. DOI: 10.1136/hrt.26.4.544. View

Asakura H, Hifumi S, Jokaji H, Saito M, Kumabashiri I, Uotani C . Prothrombin fragment F1 + 2 and thrombin-antithrombin III complex are useful markers of the hypercoagulable state in atrial fibrillation. Blood Coagul Fibrinolysis. 1992; 3(4):469-73. View

Rowe J, BLAND E, SPRAGUE H, White P . The course of mitral stenosis without surgery: ten- and twenty-year perspectives. Ann Intern Med. 1960; 52:741-9. DOI: 10.7326/0003-4819-52-4-741. View

Bounameaux H, Cirafici P, de Moerloose P, Schneider P, Slosman D, Reber G . Measurement of D-dimer in plasma as diagnostic aid in suspected pulmonary embolism. Lancet. 1991; 337(8735):196-200. DOI: 10.1016/0140-6736(91)92158-x. View

Connolly S, Laupacis A, Gent M, Roberts R, Cairns J, Joyner C . Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol. 1991; 18(2):349-55. DOI: 10.1016/0735-1097(91)90585-w. View

. Stroke Prevention in Atrial Fibrillation Study. Final results. Circulation. 1991; 84(2):527-39. DOI: 10.1161/01.cir.84.2.527. View

10.

Singer D, Hughes R, Gress D, Sheehan M, Oertel L, Maraventano S . The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med. 1990; 323(22):1505-11. DOI: 10.1056/NEJM199011293232201. View

11.

Petersen P, Boysen G, Godtfredsen J, Andersen E, Andersen B . Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet. 1989; 1(8631):175-9. DOI: 10.1016/s0140-6736(89)91200-2. View

12.

Bounameaux H, Schneider P, Reber G, de Moerloose P, Krahenbuhl B . Measurement of plasma D-dimer for diagnosis of deep venous thrombosis. Am J Clin Pathol. 1989; 91(1):82-5. DOI: 10.1093/ajcp/91.1.82. View

13.

. Cardiogenic brain embolism. Cerebral Embolism Task Force. Arch Neurol. 1986; 43(1):71-84. View

14.

Chesebro J, Adams P, Fuster V . Antithrombotic therapy in patients with valvular heart disease and prosthetic heart valves. J Am Coll Cardiol. 1986; 8(6 Suppl B):41B-56B. DOI: 10.1016/s0735-1097(86)80006-7. View

15.

Roberts W, Siegel R, McManus B . Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients. Am J Cardiol. 1987; 60(16):1340-55. DOI: 10.1016/0002-9149(87)90618-7. View

16.

Kyrle P, Korninger C, Gossinger H, Glogar D, Lechner K, Niessner H . Prevention of arterial and pulmonary embolism by oral anticoagulants in patients with dilated cardiomyopathy. Thromb Haemost. 1985; 54(2):521-3. View

17.

Hardarson T, de la Calzada C, Curiel R, Goodwin J . Prognosis and mortality of hypertrophic obstructive cardiomyopathy. Lancet. 1973; 2(7844):1462-7. DOI: 10.1016/s0140-6736(73)92730-x. View

18.

SELZER A, Cohn K . Natural history of mitral stenosis: a review. Circulation. 1972; 45(4):878-90. DOI: 10.1161/01.cir.45.4.878. View

19.

Adams G, Merrett J, HUTCHINSON W, Pollock A . Cerebral embolism and mitral stenosis: survival with and without anticoagulants. J Neurol Neurosurg Psychiatry. 1974; 37(4):378-83. PMC: 494667. DOI: 10.1136/jnnp.37.4.378. View

20.

Johnsson H, ORINIUS E, Paul C . Fibrinopeptide a (FPA) in patients with acute myocardial infarction. Thromb Res. 1979; 16(1-2):255-60. DOI: 10.1016/0049-3848(79)90286-x. View